CoChat

Tachyphylaxis after Repeated Antidepressant Drug Exposure in Patients with Recurrent Major Depressive Disorder

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Objective: The aim of this post hoc analysis was to examine whether tachyphylaxis occurs after repeated courses of antidepressant drug therapy. Method: 276 patients with major depressive disorder (MDD) were treated with sertraline (150–200 mg daily) for 8 weeks. Patients with persistent MDD after sertraline therapy were randomized to continuation therapy with either sertraline plus atomoxetine (n = 72) or sertraline plus placebo (n = 74) for 8 additional weeks. Logistic regression was used to test the hypothesis that an increase in prior antidepressant drug exposure is associated with a reduced responsiveness to sertraline therapy. Results: The number of prior antidepressant drug exposures was negatively associated with response to initial sertraline therapy (odds ratio = 0.81, p = 0.0035). The odds ratio indicates a 19.9% reduced likelihood of response with each prior antidepressant treatment trial. In contrast, the number of prior antidepressant treatment trials was not associated with response to continuation sertraline plus atomoxetine or sertraline plus placebo therapy. Conclusion: This observation supports the hypothesis that tachyphylaxis may develop after repeated antidepressant drug trials.

Overview

Integrity signals

Registry

Crossref · 10.1159/000226611

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 7

  1. 10.1016%2fj.jad.2005.06.011 · DOI
  2. 10.4088%2fjcp.v68n1014 · DOI · Paper page
  3. 10.4088%2fjcp.1007e23 · doi:10.4088/jcp.1007e23
  4. 10.1016%2f0306-9877%2884%2990018-5 · DOI · Paper page
  5. 10.1176%2fappi.ajp.163.11.1905 · doi:10.1176/appi.ajp.163.11.1905 · Paper page
  6. 10.1176%2fappi.ajp.163.7.1161 · doi:10.1176/appi.ajp.163.7.1161 · Paper page
  7. 10.1176%2fappi.ajp.163.9.1531 · DOI

Cited by

See all 40

Metadata

Authors
Amsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F.
Affiliations
  • University of Pennsylvania (US)
  • Eli Lilly (United States) (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • New York University (US)
  • Harvard University (US)
  • University of Utah (US)
  • Stanford Medicine (US)
Venue
Neuropsychobiology
Publisher
S. Karger AG
Published
2009
Volume
59
Issue
4
Pages
227-233
ISSN
  • 0302-282X (ISSN-L)
  • 1423-0224
OpenAlex
W2014544184
Cited by
39
References
39
Citations by year
2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 5 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
FWCI
2.63
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neuropsychobiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
tachyphylaxis, antidepressant resistance, recurrent major depressive disorder, sertraline, atomoxetine, treatment response, continuation treatment, selective serotonin reuptake inhibitors
MeSH terms
Atomoxetine Hydrochloride, Antidepressive Agents, Major Depressive Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Propylamines, Recurrence, Tachyphylaxis, Logistic Models, Odds Ratio, Treatment Outcome, Adrenergic Uptake Inhibitors, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.